Porvair Filtration Group Receives Queen’s Award for Enterprise in International Trade
News Apr 21, 2015
The Queen’s Awards for Enterprise provide an opportunity to celebrate and encourage excellence in UK business; given only to companies or individuals who are outstanding in their field, they recognise achievements across three categories: international trade, sustainable development, and innovation.
Each category has a separate judging panel which makes a recommendation to the Prime Minister’s Advisory Committee. The committee then makes a final recommendation to Her Majesty The Queen, who decides the winners.
Since 2011, the company has seen its export sales rise by 140%, amounting to 69 per cent of its total sales from its UK operations.
The significant increase in export has been due to the company’s success in markets such as coal gasification in Asia, Bioscience and Nuclear in the USA and general industrial process filtration in Europe.
The Group’s top export markets have been identified as USA, India, South Korea and Germany.
Porvair’s Managing Director, Tom Liddell said: “It is an honour for our company to receive this award and to be recognised for our success in exporting our products manufactured in the UK. Whilst growing international business can be challenging, we have found a significant appetite for quality products manufactured by our skilled and dedicated staff in the UK.
“We believe the award represents a significant milestone for the business, one that will serve to enhance our reputation at home and overseas. We anticipate further, sustainable growth in the years to come.”
Two Porvair representatives will be invited to attend a special reception at Buckingham Palace on 14th July. The presentation of a Grant of Appointment, symbolised by a crystal bowl, will also take place at Porvair’s Head Office later in the year.
Porvair Filtration Group – which has supplied the aerospace, nuclear, energy, process and bioscience industries with performance-driven filtration equipment for almost 30 years – manufactures in both the UK and USA and has an extensive network of sales offices and distribution channels throughout the world.
Avacta Group plc announces successful outcome of “Gene Delivery” collaboration with FIT BiotechNews
Sustained production of Affimer drugs by muscle tissue in vivo could lead to major patient and commercial benefits.READ MORE
SCRaMbLE Speeds Up Yeast EvolutionNews
Scientists have created a new way of speeding up the genome evolution of baker’s yeast Saccharomyces cerevisiae. This is to develop a synthetic yeast strain that can be transformed on demand, making it industrial applications such as the mass production of advanced medicines to treat illnesses such as malaria and tuberculosis (TB).READ MORE
Artificial Cellular Compartments BuiltNews
How to install new capabilities in cells without interfering with their metabolic processes? A team from the Technical University of Munich (TUM) and the Helmholtz Zentrum München have altered mammalian cells in such a way that they formed artificial compartments in which sequestered reactions could take place, allowing the detection of cells deep in the tissue and also their manipulation with magnetic fields.READ MORE